BR0316482A - Processo aperfeiçoado para a preparação de indenos 1,3 substituìdos - Google Patents

Processo aperfeiçoado para a preparação de indenos 1,3 substituìdos

Info

Publication number
BR0316482A
BR0316482A BR0316482-9A BR0316482A BR0316482A BR 0316482 A BR0316482 A BR 0316482A BR 0316482 A BR0316482 A BR 0316482A BR 0316482 A BR0316482 A BR 0316482A
Authority
BR
Brazil
Prior art keywords
improved process
preparing
indenes
substituted indenes
substituted
Prior art date
Application number
BR0316482-9A
Other languages
English (en)
Inventor
Robert Eugene Handfield Jr
Phillip James Johnson
Peter Robert Rose
Timothy James Norman Watson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0316482A publication Critical patent/BR0316482A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Circuit Arrangements For Discharge Lamps (AREA)

Abstract

"PROCESSO APERFEIçOADO PARA A PREPARAçãO DE INDENOS 1,3 SUBSTITUìDOS". A presente invenção refere-se a um processo aperfeiçoado para a preparação de indenos 1,3 substituídos que são intermediários úteis na síntese de compostos arila aza-policíclicos condensados como agentes para o tratamento de distúrbios neurológicos e psicológicos.
BR0316482-9A 2002-11-25 2003-11-12 Processo aperfeiçoado para a preparação de indenos 1,3 substituìdos BR0316482A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42902902P 2002-11-25 2002-11-25
PCT/IB2003/005121 WO2004048318A1 (en) 2002-11-25 2003-11-12 Improved process for the preparation of 1,3-substituted indenes

Publications (1)

Publication Number Publication Date
BR0316482A true BR0316482A (pt) 2005-10-11

Family

ID=32393492

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316482-9A BR0316482A (pt) 2002-11-25 2003-11-12 Processo aperfeiçoado para a preparação de indenos 1,3 substituìdos

Country Status (16)

Country Link
US (1) US7285686B2 (pt)
EP (1) EP1567483A1 (pt)
JP (1) JP2006507342A (pt)
KR (1) KR100655848B1 (pt)
CN (1) CN1714075A (pt)
AR (1) AR042205A1 (pt)
AU (1) AU2003278510B8 (pt)
BR (1) BR0316482A (pt)
CA (1) CA2511762A1 (pt)
MX (1) MXPA05005517A (pt)
PL (1) PL377292A1 (pt)
RS (1) RS20050393A (pt)
RU (1) RU2284319C2 (pt)
TW (1) TWI245756B (pt)
WO (1) WO2004048318A1 (pt)
ZA (1) ZA200503190B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009504852A (ja) 2005-08-11 2009-02-05 ユニバーシティ オブ マサチューセッツ ロウエル オレフィンおよび保護または非保護のヒドロキシスチレン単位を含む共重合体を形成するための方法
EP2268639A2 (en) 2008-05-22 2011-01-05 Teva Pharmaceutical Industries Ltd. Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
WO2009155403A2 (en) * 2008-06-19 2009-12-23 Teva Pharmaceutical Industries Ltd. Processes for the preparation of varenicline and intermediates thereof
US20100010221A1 (en) * 2008-07-10 2010-01-14 Revital Lifshitz-Liron Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt
WO2010151524A1 (en) 2009-06-22 2010-12-29 Teva Pharmaceutical Industries Ltd Solid states forms of varenicline salts and processes for preparation thereof
US20160296438A1 (en) * 2015-04-08 2016-10-13 Kemin Industries, Inc. Protective action of lutein against blue light on human skin cell lines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136727A0 (en) 1997-12-31 2001-06-14 Pfizer Prod Inc Aryl fused azapolycyclic compounds
US6605610B1 (en) 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
BR0208992A (pt) * 2001-04-20 2004-04-27 Pfizer Prod Inc Processo para a preparação de indenos 1,3-substituìdos e compostos azapolicìclicos fundidos com arila
WO2004046077A1 (en) 2002-11-20 2004-06-03 Pfizer Products Inc. A method for preparing indan-1,3-dicarboxylic acid
MXPA05007565A (es) 2003-01-15 2005-09-21 Pfizer Prod Inc Procedimiento mejorado de preparacion de lactamas policiclicas fusionadas con arilos.

Also Published As

Publication number Publication date
MXPA05005517A (es) 2005-07-25
WO2004048318A1 (en) 2004-06-10
WO2004048318A8 (en) 2005-05-12
AU2003278510A1 (en) 2004-06-18
RU2005115881A (ru) 2006-02-27
AU2003278510B8 (en) 2008-07-10
TW200413301A (en) 2004-08-01
EP1567483A1 (en) 2005-08-31
ZA200503190B (en) 2006-07-26
AU2003278510B2 (en) 2008-06-05
PL377292A1 (pl) 2006-01-23
KR20050087801A (ko) 2005-08-31
TWI245756B (en) 2005-12-21
JP2006507342A (ja) 2006-03-02
US20050004379A1 (en) 2005-01-06
RU2284319C2 (ru) 2006-09-27
KR100655848B1 (ko) 2006-12-11
US7285686B2 (en) 2007-10-23
CN1714075A (zh) 2005-12-28
RS20050393A (en) 2007-12-31
CA2511762A1 (en) 2004-06-10
AR042205A1 (es) 2005-06-15

Similar Documents

Publication Publication Date Title
BR0311494A (pt) Novos indóis substituìdos
BR0312729A (pt) Novos derivados de indol-3-enxofre
BR0307721A (pt) Processo para preparação de derivados de indolinona
UY28144A1 (es) Agentes terapéuticos
BRPI0410711A (pt) novos compostos
BR0314611A (pt) Compostos de tiazol para o tratamento de distúrbios neurodegenerativos
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
UY26813A1 (es) Compuestos para tratar enfermedad de alzheimer
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
BR0013311A (pt) Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor
UY28484A1 (es) Compuestos para el tratamiento de trastornos neurodegenerativos
BR0208534A (pt) Processo para preparação de 4,6-diaminopirimido[5,4-d]pirimidinas
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
BR0316482A (pt) Processo aperfeiçoado para a preparação de indenos 1,3 substituìdos
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos
BR9808923A (pt) Composto, e, processo para fazer o mesmo
BR0016942A (pt) Derivados substituìdos de aminometil-fenil-ciclohexano
BR0011996A (pt) Preparação de piperidin-4-onas substituìdas
BR0316392A (pt) Processo para preparar ácido indan-1,3-dicarboxìlico
BRPI0411652A (pt) processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos
BR0214529A (pt) compostos terapêuticos
BR0113170A (pt) Processo para a preparação de dinapsolina
PT1347960E (pt) Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.